TNFSF10 and cancer: Several current anti-tumor therapies induce apoptosis in cancer cells using antibody delivery of toxic molecules, antibody binding to death receptors such as TRAIL followed by apoptotic induction, and inhibition of histone deacetylases (HDACs) leading to apoptotic induction [74]–[76].